Citation Impact

Citing Papers

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
SUBCLINICAL REJECTION AND BORDERLINE CHANGES IN EARLY PROTOCOL BIOPSY SPECIMENS AFTER RENAL TRANSPLANTATION
2004
Treating hepatitis C infection in liver transplant recipients
2006
Hepatitis C and liver transplantation
2005 Nature
Hepatocellular carcinoma
2018 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
No Difference in Degree of Interstitial Sirius Red–Stained Area in Serial Biopsies from Area under Concentration-over-Time Curves–Guided Cyclosporine versus Tacrolimus-Treated Renal Transplant Recipients at One Year
2005
The Utility of 1- and 3-Month Protocol Biopsies on Renal Allograft Function: A Randomized Controlled Study
2008
Outcomes of patients with hepatitis C undergoing simultaneous liver–kidney transplantation
2009
Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation
2016 StandoutNobel
Post-liver-transplant anemia: Etiology and management
2004
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations
2004
Kidney Allocation to Liver Transplant Candidates with Renal Failure of Undetermined Etiology: Role of Percutaneous Renal Biopsy
2008
Macrophages in immunoregulation and therapeutics
2023 Standout
The Generation of Donor-Specific CD4+CD25++CD45RA+ Naive Regulatory T Cells in Operationally Tolerant Patients After Pediatric Living-Donor Liver Transplantation
2010 StandoutNobel
Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine Values
2007 Standout
Liver grafts from anti-hepatitis B core positive donors: A systematic review
2009
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Baseline Immunosuppression is Associated with Histological Findings in Early Protocol Biopsies
2004
Clinical Diagnosis of an Anterior Cruciate Ligament Rupture: A Meta-analysis
2006
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
2014 StandoutNobel
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections
2014
Treating hepatitis C
2005 StandoutNobel
Transplant trials with Tregs: perils and promises
2017
Evaluation of Renal Function in Liver Transplant Recipients Receiving Daclizumab (Zenapax), Mycophenolate Mofetil, and a Delayed, Low-Dose Tacrolimus Regimen Vs. a Standard-Dose Tacrolimus and Mycophenolate Mofetil Regimen
2005
The Significance of Subclinical Rejection and the Value of Protocol Biopsies
2006
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production
2015 StandoutNobel
Natural History, Risk Factors, and Impact of Subclinical Rejection in Kidney Transplantation
2004
Independent risk factors and natural history of renal dysfunction in liver transplant recipients
2003
An Appraisal of Tolerance in Liver Transplantation
2006
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
Anemia of Chronic Disease
2005 Standout
Lack of Benefit of Early Protocol Biopsies in Renal Transplant Patients Receiving TAC and MMF: A Randomized Study
2007
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
Evolution of Endpoints for Renal Transplant Outcome
2003
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
2018
Regulatory T Cells and Human Disease
2020 StandoutNobel
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
2006 Standout
2020 European guideline on the management of syphilis
2020 Standout
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
Organization of the genetic locus for chicken myosin light chain kinase is complex: Multiple proteins are encoded and exhibit differential expression and localization
1998
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Towards a small animal model for hepatitis C
2009 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Developments in liver transplantation
2004

Works of Ari Cohen being referenced

Subclinical Rejection in Tacrolimus-Treated Renal Transplant Recipients
2002
??4 INTEGRIN IN ISLET ALLOGRAFT REJECTION1
2001
The chick type III collagen gene contains two promoters that are preferentially expressed in different cell types and are separated by over 20 kb of DNA containing 23 exons
1997
Chronic renal dysfunction late after liver transplantation
2002
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1
2003
Tolerance: Is It Worth the Risk?
2005
Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?
2003
Thrombolytic protocol minimizes ischemic‐type biliary complications in liver transplantation from donation after circulatory death donors
2014
The value of magnetic resonance imaging in our current management of ACL and meniscal injuries
2007
Rankless by CCL
2026